PHR (Phreesia) ROE % Adjusted to Book Value : -5.46% (As of Oct. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Phreesia ROE % Adjusted to Book Value?

Phreesia's ROE % for the quarter that ended in Oct. 2024 was -22.77%. Phreesia's PB Ratio for the quarter that ended in Oct. 2024 was 4.17. Phreesia's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 was -5.46%.

Phreesia ROE % Adjusted to Book Value Historical Data

The historical data trend for Phreesia's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phreesia ROE % Adjusted to Book Value Chart

Phreesia Annual Data

Trend

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-1.35

-8.97

-7.21

-8.89

Phreesia Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-17.40	-8.32	-6.64	-4.99	-5.46

Competitive Comparison of Phreesia's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Phreesia's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phreesia's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Phreesia's ROE % Adjusted to Book Value falls into.

Phreesia ROE % Adjusted to Book Value Calculation

Phreesia's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-50.77%	/	5.71
	=	-8.89%

Phreesia's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-22.77%	/	4.17
	=	-5.46%

Phreesia ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Phreesia's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Phreesia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Phreesia Inc (NYSE:PHR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0A23:UK 19P:Germany

Address

1521 Concord Pike, Suite 301 PMB 221, Wilmington, DE, USA, 19803

Website

https://www.phreesia.com

Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.

Executives

Amy Beth Vanduyn	officer: SVP, Human Resources	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Michael Weintraub	director	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
David Linetsky	officer: SVP, Life Sciences	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Balaji Gandhi	officer: Chief Financial Officer	PHREESIA, INC., 1521 CONCORD PIKE, SUITE 301, PMB 221, WILMINGTON DE 19803
Allison C Hoffman	officer: General Counsel & Secretary	315 EAST 68TH STREET, NEW YORK NY 10065
Chaim Indig	director, officer: Chief Executive Officer	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Evan Roberts	officer: Chief Operating Officer	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
Mark Douglas Smith	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Janet Gunzburg	officer: Principal Accounting Officer	BANKRATE, INC., 477 MADISON AVENUE, SUITE 430, NEW YORK NY 10022
Michael J. Davidoff	officer: See Remarks	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Gillian Munson	director	C/O XO GROUP INC., 195 BROADWAY, 25TH FLOOR, NEW YORK NY 10007
Randy Rasmussen	officer: Chief Financial Officer	PHREESIA, INC., 434 FAYETTEVILLE ST., SUITE 1400, RALEIGH NC 27601
Ramin Sayar	director	305 MAIN STREET, REDWOOD CITY CA 94063
Edward L Cahill	10 percent owner	C/O HLM VENTURE PARTNERS, 800 SOUTH STREET, SUITE 200, WALTHAM MA 02453